Inmed Pharmaceuticals Inc. [IMLFF]

Source: 

Company Overview

Inmed Pharmaceuticals Inc. is a pharmaceutical company developing a pipelineof proprietary small molecule drug candidates that are preferential signaling ligands of the endogenous cannabinoid 1 (“CB1”)and cannabinoid 2 (“CB2”) receptors as well as other receptor targets linked to human diseases.